Back to Search Start Over

Biosimilar Ranibizumab (SB11) vs Reference Ranibizumab-Diving Deeper for Safety and Efficacy-Reply

Authors :
Neil M. Bressler
Source :
JAMA ophthalmology. 139(6)
Publication Year :
2021

Subjects

Subjects :
medicine.medical_specialty
business.industry
MEDLINE
Biosimilar
Angiogenesis Inhibitors
Ophthalmology
Ranibizumab
Intravitreal Injections
medicine
Humans
Intensive care medicine
business
Biosimilar Pharmaceuticals
medicine.drug

Details

ISSN :
21686173
Volume :
139
Issue :
6
Database :
OpenAIRE
Journal :
JAMA ophthalmology
Accession number :
edsair.doi.dedup.....6be05966b08b26f20abcd47003720c17

Tools

Authors Abstract Subjects Details